Key facts
- The core problem
- The brain is opaque, encased in bone, microscopic in scale and fast in time
- The core trade-off
- Spatial resolution, temporal resolution and invasiveness cannot all be maximised
- Best spatial detail (non-invasive)
- MRI, below one millimetre for structure
- Best temporal detail (non-invasive)
- EEG and MEG, on the order of a millisecond
- Only molecular imaging
- PET, which can map specific receptors and protein deposits
- Causal methods in humans
- TMS and lesion evidence; imaging alone is correlational
- Most common error
- Reverse inference: reading a mental state off a region that is active
The problem every method is trying to solve
Almost every other organ can be studied by opening it up, cutting a piece out, or watching it move. The brain resists all three. It is enclosed in the skull, which is opaque to visible light and hostile to most forms of access. Its functional units, the neurons and the synapses between them, are measured in micrometres. And the events that matter, the action potentials and synaptic potentials that constitute its work, are over in a few thousandths of a second.
So there is no method that simply "shows the brain thinking". Every technique makes a bargain, and the bargain is always struck along three axes at once.
The three axes.Spatial resolution is how precisely a method can say where a signal came from: can it distinguish two structures a millimetre apart, or does it only know that something happened somewhere under the left side of the head? Temporal resolution is how precisely it can say when: can it separate two events ten milliseconds apart, or does it only see an average over ten seconds? Invasiveness is what the measurement costs the participant: nothing at all, a magnetic field, a dose of ionising radiation, a hole in the skull, or an experiment that can only be done in an animal. Improve one axis and you almost always pay on another.
Understanding a method therefore means understanding its bargain. It is not enough to know that fMRI "shows brain activity"; you have to know that it does so by watching blood, several seconds late, and that this single fact determines almost every question it can and cannot answer. What follows walks through the major methods with that discipline: what it measures, what it is genuinely good for, and where its hard limit lies.
Structural MRI: exquisite anatomy, silent about function
Magnetic resonance imaging exploits a property of hydrogen nuclei, which are abundant in the body because the body is largely water. Placed in a very strong magnetic field, these nuclei align with it. A radiofrequency pulse knocks them out of alignment, and as they settle back they emit a faint signal whose timing depends on the local chemical environment. Fat, water, grey matter and white matter relax at measurably different rates, so the machine can distinguish them. Magnetic gradients encode position, allowing the signal to be reconstructed into a three-dimensional image.
The result is the most detailed non-invasive picture of the living human brain that exists, resolving structures below a millimetre, with no ionising radiation. It is why a person with a suspected tumour, a suspected multiple sclerosis plaque, or a suspected stroke goes into an MRI scanner. It is also the basis of morphometric research, which measures cortical thickness, the volume of the hippocampus, or the integrity of white matter tracts.
Its limit is absolute and easily forgotten. Structural MRI is a photograph. It tells you the shape of the tissue and nothing whatsoever about what that tissue is doing. A brain that is thinking hard and a brain that is anaesthetised produce the same structural scan. Every claim about function that appears to come from an MRI machine actually comes from a different sequence run on the same hardware, which is the subject of the next section.
fMRI: why the most famous method measures blood, not thought
Functional MRI is the technique behind almost every brain image the public ever sees, and it is the most systematically misunderstood method in neuroscience. The misunderstanding has a single root: people assume it records neural activity. It does not. It records blood.
Here is the actual causal chain, which is worth following link by link.
Neurons work, and working costs energy
A population of neurons becomes more active. Sustaining and restoring their electrical gradients consumes adenosine triphosphate, and regenerating that ATP consumes oxygen and glucose. This is covered in detail under brain energy and metabolism.
The local blood supply responds, and overshoots
Through a process called neurovascular coupling, signals released by neurons and by astrocytes cause nearby arterioles to dilate, and local blood flow rises. Crucially, the flow increase exceeds what the tissue actually extracts. More oxygenated blood arrives than is consumed.
The magnetic properties of the blood change
Haemoglobin carrying oxygen is diamagnetic; haemoglobin that has given up its oxygen is paramagnetic, meaning it distorts the surrounding magnetic field. Because the flow overshoot reduces the local proportion of deoxygenated haemoglobin, that field distortion decreases, and the MRI signal in that voxel rises slightly.
The scanner detects the change, several seconds late
This is the blood-oxygen-level-dependent, or BOLD, response. It begins about a second or two after the neural event, peaks at roughly four to six seconds, and takes many seconds more to return to baseline. The neural event itself lasted milliseconds.
The BOLD signal is a proxy, and this is not a technicality. It is an inference: neurons were probably busier here, because the blood here got more oxygenated a few seconds later. The relationship between neural activity and BOLD is real and has been directly validated by simultaneous electrical recording and scanning, most influentially by Nikos Logothetis and colleagues, whose work indicated that BOLD tracks local synaptic and dendritic processing (local field potentials) more closely than it tracks the output spiking of the neurons. That is an important distinction: a region can show a BOLD increase because a great deal of input is arriving there, even when its own output has not changed, and it can show a BOLD increase from inhibitory processing, which is metabolically expensive but reduces firing. "Active" in an fMRI paper does not mean "firing more".
What follows from all of this is a precise account of the method's strengths and its ceiling. Spatially, fMRI is good: typical voxels are a few millimetres on a side, and it sees the whole brain including deep structures such as the basal ganglia and the thalamus that scalp electrical methods cannot reach. Temporally, it is poor and irreparably so: even a perfect scanner cannot beat the sluggishness of the blood response it depends on. And, most importantly of all, it is correlational. An fMRI experiment shows that a region's blood oxygenation changed while a person did a task. It cannot show that the region was doing the task, that it was necessary for the task, or that the task could not have been done without it. That question requires a different class of method entirely.
What an fMRI image really is. The picture you see, with its warm blobs on a grey brain, is not a photograph of activity. It is a statistical map of a difference. The experimenter compares the BOLD signal in one condition against another (looking at faces versus looking at houses, say), tests every voxel separately, and colours in the voxels whose difference passes a chosen threshold. The blob is a set of test results. Nothing lit up, nothing switched on, and the grey areas were not idle: they simply did not differ enough between the two conditions to pass the threshold.
EEG and MEG: the only methods fast enough to watch the brain work
If fMRI is slow because it watches blood, the electromagnetic methods are fast because they watch the electricity itself.
EEG
Electrodes on the scalp record voltage fluctuations produced by the summed postsynaptic potentials of large, parallel-aligned populations of cortical pyramidal neurons. Temporal resolution is superb, on the order of a millisecond. The hard limit is spatial: the skull is a poor conductor and acts as a blur filter, smearing each source across a wide patch of scalp, and working backwards from a scalp map to its sources has no unique solution. Deep structures are largely invisible. EEG is treated in full on the dedicated page for brain waves and EEG, including the frequency bands, event-related potentials and the substantial pseudoscience that surrounds the method.
MEG
Magnetoencephalography detects the extremely faint magnetic fields generated by the same neuronal currents that produce the EEG. Its advantage is physical: magnetic fields pass through the skull and scalp far less distorted than electric currents do, so source localisation is meaningfully better while temporal resolution stays at the millisecond scale. The costs are severe. The fields involved are on the order of a hundred million times weaker than the Earth's magnetic field, so MEG requires superconducting sensors, cryogenic cooling and a magnetically shielded room. It is one of the most expensive tools in the field, it is available in relatively few centres, and it remains preferentially sensitive to sources in the cortical sulci because of the geometry of the currents involved.
The pairing is instructive. EEG and MEG measure the same underlying biophysical event and differ mainly in what the head does to the signal on its way out. That a change of physical medium, from electric to magnetic, buys you spatial precision at a cost of a shielded room and a cryogenic dewar is a fair illustration of how the trade-offs in this field actually work: they are not arbitrary, they follow from physics, and they cannot be talked away.
PET: the only method that can image a molecule
Positron emission tomography takes a wholly different approach. A molecule of biological interest is synthesised with one of its atoms replaced by a radioactive isotope that decays by emitting a positron. The tracer is injected into the bloodstream. Each emitted positron travels a short distance, meets an electron, and the pair annihilates, producing two gamma photons that fly apart in opposite directions. A ring of detectors around the head registers pairs of photons arriving simultaneously, and from many such coincidences the scanner reconstructs where in the brain the tracer accumulated.
What makes PET indispensable is not resolution. Its spatial resolution is worse than MRI and its temporal resolution is dismal, ranging from tens of seconds to minutes depending on the tracer. What makes it indispensable is chemical specificity. Choose your tracer and you choose what you image.
FDG
Fluorodeoxyglucose is a glucose analogue that is taken up like glucose but then becomes trapped inside the cell. It maps where the brain is consuming fuel, and it is the workhorse of both clinical PET and metabolic research.
Neuroreceptor ligands
Tracers that bind to a specific receptor allow the density and occupancy of that receptor to be measured in a living person. Dopamine receptor imaging is the classic example, and it is why PET is central to research on dopamine and reward, on addiction and on antipsychotic drug action. No other method can do this in a living human being.
Amyloid and tau tracers
Tracers that bind to amyloid-beta plaques or to tau tangles have transformed dementia research and diagnosis, because they reveal a specific molecular pathology in a living brain that previously could only be confirmed at autopsy.
The costs are real and set the boundary on its use. PET involves ionising radiation, which restricts how often a person can be scanned and effectively excludes healthy children and repeated study in most healthy volunteers. Many tracers are made with short-lived isotopes and require an on-site cyclotron. And the temporal resolution is such that PET can tell you what the brain's chemistry looked like over a period, never what it did in a given second.
Causal methods: the difference between active and necessary
Everything discussed so far, with the exception of nothing at all, is correlational. It records what happens while something else happens. That is a genuine limitation, and it is the deepest one in the field, because the questions people actually care about are causal: is this region doing the job, or is it merely nearby while the job is done?
There are two ways to get a causal answer in a human being, and both work by intervening rather than observing.
Transcranial magnetic stimulation
A coil held against the scalp discharges a brief, intense magnetic pulse. The changing magnetic field induces an electrical current in the cortical tissue beneath, which can either excite that tissue or, more commonly in cognitive experiments, transiently disrupt its normal processing. If disrupting a region while a person performs a task makes them slower or worse at it, that region is not merely correlated with the task. It is necessary for it, at least in the moment. This is the crucial thing TMS can do that no scanner can, and it is why the technique is disproportionately valuable relative to how modest its images look. Its limits are equally clear: the pulse reaches only cortex within a few centimetres of the skull, so deep structures are out of reach, the spatial focus is coarse compared with a scan, and the disruption spreads through the network to which the stimulated region belongs, so a negative result somewhere else in that network is not necessarily innocent.
Lesion studies
The oldest causal method in neuroscience, and still one of the most powerful. If damage to a region reliably abolishes a function, that region was necessary for it. Broca's and Wernicke's observations of aphasia after specific left-hemisphere damage founded the study of language and the brain, and the amnesia of the patient known as H.M. after bilateral removal of the medial temporal lobes established the role of the hippocampus in forming new memories more decisively than any scan has since. The limits, however, are severe and are routinely underweighted. A lesion is not an experiment: it lands where a blood vessel occluded or a tumour grew, not where an experimenter wanted it. Lesions are almost never anatomically tidy, so they damage passing fibres as well as the intended region. And the brain reorganises after injury, so a deficit measured a year on may reflect the compensation as much as the damage.
Why this section matters more than the pretty pictures. An enormous proportion of popular neuroscience consists of correlational imaging results reported in causal language: this region "controls" empathy, that one "drives" impulsivity. The imaging did not and could not show that. When you meet such a claim, the question to ask is whether anyone intervened. If nobody switched the region off and watched the behaviour change, the causal word in the headline was supplied by the journalist, not by the data.
The animal methods, and why they are the gold standard
Almost everything mechanistic that is known about how neurons compute was learned by methods that cannot be used on people, and it is worth being explicit about this, because it explains why so many confident popular claims about the human brain are extrapolations.
Single-unit recording means lowering a fine microelectrode into the brain until its tip is close enough to a single neuron to register that neuron's individual action potentials. The resolution is exquisite: you are watching one cell, spike by spike, in real time. This is how the visual cortex's orientation-selective cells were discovered, how place cells and grid cells were found in and around the hippocampus, and how much of what we know about how information is coded in firing rates was established. Multi-electrode arrays now record hundreds of cells at once. In humans it is possible only in rare clinical circumstances, chiefly in epilepsy patients who already have electrodes implanted for surgical planning.
Optogenetics goes one step further and is worth understanding properly, because it is the reason the last two decades of systems neuroscience look the way they do. Certain algae and bacteria make light-sensitive ion channels, proteins that open when struck by light of a particular colour. Using genetic techniques, these channels can be inserted into a chosen population of neurons in a living animal, and into that population only, targeted by cell type. An optical fibre then delivers light to the region. Because opening an ion channel changes the neuron's membrane potential, a flash of light can now switch that specific class of neurons on, or, with a different opsin, off, on a millisecond timescale, in a behaving animal.
Why optogenetics changed everything: it is simultaneously causal, cell-type specific and temporally precise. Before it, you could correlate the activity of a region with a behaviour, or lesion the region crudely and permanently. Now you can silence one genetically defined class of neurons in one region for exactly the two hundred milliseconds during which an animal makes a decision, and see whether the decision changes. That combination is unavailable in humans by any method, which is precisely why the strongest mechanistic claims in neuroscience are made about rodents and the weakest are made about us. Compare the honest treatment of exactly this gap in the entry on neurogenesis.
The trade-off, stated plainly
The whole methodological landscape can be compressed into a single observation: nobody has a method that is simultaneously precise in space, precise in time, non-invasive and causal. Choose three at most, and usually two.
Read down that list and a strategy suggests itself, and it is the strategy good laboratories actually use: converge. Combine methods whose weaknesses do not overlap. Use fMRI to find out where, EEG or MEG to find out when, TMS or lesion evidence to find out whether it is necessary, and animal work to find out how the cells do it. A conclusion supported by one method is a hypothesis. A conclusion supported by four methods with independent failure modes is knowledge.
How brain imaging is misused
This is the section that matters most, and it is worth dwelling on. Neuroimaging is not a fringe field peddling nonsense; it is a serious and productive science. But its outputs are unusually easy to misread, partly because the images are so persuasive, and there are four specific failures that recur relentlessly, in the press and sometimes in the literature.
1. Nothing "lights up"
The phrase "the X centre lit up" is not merely loose language; it encodes a false picture of what happened. There is no light. There is no centre being switched on. The brain does not have quiet regions that activate when needed; the whole brain is metabolically busy at all times, which is exactly why it consumes about a fifth of the body's energy while you do nothing (see brain energy and metabolism). What an fMRI experiment produces is a difference: the signal in condition A minus the signal in condition B, tested voxel by voxel, with the voxels that cross a statistical threshold coloured in. The coloured blob is where the difference was reliable. The uncoloured brain is not switched off. It simply did not differ between the two conditions the experimenter happened to compare, and if the experimenter had compared different conditions, a different blob would have appeared.
2. Reverse inference
This is the central logical error of popular neuroscience, and it was named and dissected by Russell Poldrack in 2006. The reasoning runs: in this experiment, region R was active; in previous studies, region R has been associated with mental state M; therefore the participants were experiencing M.
Why reverse inference fails. The inference would only be sound if region R were active when and only when M occurs. It almost never is. Take the insula, a favourite of the genre: it is reliably active in disgust, and also in pain, in interoceptive awareness, in risk, in craving, in empathy and in a great many other tasks. Finding insula activity therefore tells you very little about which of those states the person was in. The formal point is Bayesian: to move from "R is active" to "M is present" you need to know how selective R is for M, which means knowing how often R is active in the absence of M across the whole space of tasks. In most cases that base rate is high, which makes the inference weak. Poldrack's own analysis of the literature found that regions commonly cited in reverse-inference claims were in fact active across enormous numbers of unrelated studies.
Once you can see this error you will find it everywhere: the neuromarketing study that claims consumers "loved" a product because a reward-associated region was active; the courtroom claim that a defendant's scan reveals a lack of empathy; the headline claiming that a scan shows people are "addicted" to their phones because a dopamine-associated region responded. Each is a reverse inference, and each is a fallacy.
3. Multiple comparisons, and the dead salmon
A functional scan divides the brain into voxels, and a typical whole-brain analysis contains tens of thousands of them. The standard analysis tests each voxel separately for a difference between conditions. Now consider what a significance threshold of p < 0.05 means: it means that, when there is no real effect at all, a given test will nevertheless come out "significant" about five per cent of the time by chance. Run that test on forty thousand voxels with no real effect anywhere, and you should expect roughly two thousand voxels to pass. Some of them will be adjacent, and adjacent significant voxels form a cluster, and a cluster looks exactly like a finding.
This is not a hypothetical. Craig Bennett and colleagues made the point unforgettably by placing a dead Atlantic salmon in an fMRI scanner, showing it photographs of humans in social situations, and asking it to determine what emotion the people were experiencing. Analysing the data without correcting for multiple comparisons, they found a cluster of "significantly active" voxels in the dead fish's brain cavity. The fish was, they noted drily, not alive at the time of scanning. The work, presented in 2009 and published in 2010, was a deliberate demonstration, and its target was not fMRI but a sloppy practice within it: at the time, a substantial fraction of published papers were not correcting properly. The remedy is standard and well understood, involving corrections such as controlling the family-wise error rate or the false discovery rate, and it is now expected. But the salmon remains the clearest available illustration of why an uncorrected blob is worth nothing.
4. Small samples and low power
Neuroimaging is expensive. Scanner time costs hundreds of pounds an hour, which for many years pushed studies toward samples of fifteen or twenty participants. A small sample means low statistical power, and low power has two consequences that are widely misunderstood. The first is the obvious one: you will miss real effects. The second is worse and less intuitive: among the effects that do reach significance in an underpowered study, a higher proportion are false positives, and the true effects that survive are systematically overestimated in size, because only an unusually large sample estimate could have crossed the threshold. A literature built on small studies therefore accumulates findings that are too few, too large, and too often wrong, and it replicates poorly. The field has recognised this, and the response has been a move toward much larger samples, data sharing, and pre-registration of analysis plans, which is a genuine and creditable reform. But a great deal of the older literature, including much of what has filtered into popular knowledge, was produced under the old regime.
The analytic flexibility problem. Underlying all four failures is something more general. An fMRI dataset must be put through a long pipeline of choices before any result appears: how to correct for head motion, how to smooth, how to align to a template, which model of the haemodynamic response to assume, which voxels to include, which threshold to apply. Each choice is defensible, and there are many of them, so the number of possible analyses of a single dataset runs into the thousands. If a researcher tries several and reports the one that worked, the reported p-value is meaningless, and this can happen without anyone intending to deceive. Pre-registering the analysis before seeing the data is the only reliable defence.
Myths about brain scans
Claim: brain scans can read your mind.
They cannot, and the gap between what decoding research has achieved and what the phrase implies is enormous. It is true that machine-learning classifiers trained on fMRI data can, within a single individual, in a single scanning session, after extensive training on that person's own data, and within a small pre-defined set of possibilities, do better than chance at guessing which of a few categories of image someone is looking at. That is a real and interesting result. It is not mind reading. It does not generalise to a stranger, it does not work outside the trained categories, it needs the person to cooperate and hold still for a long time, and it is decoding a stimulus, not a thought. There is no scanner that can be pointed at a person to find out what they believe, whether they are lying, or what they intend.
Claim: fMRI shows the brain working in real time.
It shows blood oxygenation, and it shows it late. The haemodynamic response peaks about four to six seconds after the neural events that triggered it and takes many seconds to subside, while the neural events themselves lasted milliseconds. Watching an fMRI time course is not watching the brain think; it is watching a slow, smeared, indirect consequence of thinking, several seconds after the fact. If you genuinely need real-time, that is what EEG and MEG are for, and they buy that speed by giving up spatial precision.
Claim: we only use ten per cent of our brain.
Imaging demolished this claim rather than supporting it. Structural imaging finds no large expanse of unused tissue, and metabolic imaging finds the opposite of a mostly idle organ: the brain consumes roughly a fifth of the body's energy at rest, and the fluctuation attributable to any particular task is small against that baseline. Over the course of a day, essentially every region does identifiable work, and damage anywhere produces some deficit, which would not be true of ninety per cent spare capacity. The myth may partly survive on the visual grammar of fMRI images, in which a few small blobs appear against a grey brain, but as explained above those grey areas are not inactive: they merely failed to differ between the two conditions being compared.
Claim: an fMRI or EEG scan can diagnose depression, ADHD or autism.
No neuroimaging test is validated for the diagnosis of any common psychiatric or developmental condition. Group differences between diagnosed and undiagnosed populations exist in the literature, but a group difference with heavily overlapping distributions cannot classify an individual, which is the thing a diagnostic test must do. Clinics that offer scan-based psychiatric diagnosis are selling something the evidence does not support.
How to read a neuroimaging claim
The practical value of everything above is that it gives you a short checklist. Applied to almost any brain-imaging story, it will tell you quickly whether there is anything there.
Which method, and does it support the claim being made? A claim about when something happened cannot rest on fMRI. A claim about a receptor cannot rest on EEG. A claim about a specific molecule can only come from PET.
Is the claim causal, and did anyone intervene? If the language is "controls", "drives", "makes you", and the method was a scanner, the causal claim is unsupported. Someone must have disrupted, lesioned or stimulated the region for a causal verb to be earned.
Is it a reverse inference? If the conclusion is a mental state and the evidence is that a region was active, ask how selective that region is. Usually the answer is: not remotely selective enough.
How many participants, and was the analysis corrected and pre-registered? Twenty participants, an uncorrected threshold and a surprising result is a combination that should produce scepticism, not headlines.
Was the comparison condition sensible? Every fMRI blob is a difference against something. What that something was determines what the blob means, and it is frequently not mentioned in the press coverage at all.
None of this is a reason to distrust neuroimaging. It is a reason to read it as the practitioners themselves do: as a set of powerful but sharply limited instruments, each of which answers one kind of question well and lies convincingly about the others.
Sources
- Logothetis NK. What we can do and what we cannot do with fMRI. Nature. 2008;453(7197):869-878.
- Poldrack RA. Can cognitive processes be inferred from neuroimaging data? Trends in Cognitive Sciences. 2006;10(2):59-63.
- Purves D, Augustine GJ, Fitzpatrick D, et al. Neuroscience. 6th ed. Oxford University Press; 2018.
This page is an educational reference. It is not medical advice and does not diagnose or treat any condition.